Details of the Drug Formulaction

General Information of Drug Formulation (ID: F02143)

• Formulation Name: Azithromycin 250 mg tablet
• Company: Central Texas Community Health Centers; NuCare Pharmaceuticals; Teva Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Zithromax	(DMN4H2O)	Syphilis infection	1A6Z	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Allura red AC dye	(E00338)	33258	Colorant
Butylated hydroxytoluene	(E00336)	31404	Antioxidant
Calcium hydrogenphosphate	(E00294)	24441	Diluent
Carminic acid	(E00506)	10255083	Colorant
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Sunset yellow FCF	(E00255)	17730	Colorant
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Triacetin	(E00080)	5541	Humectant; Plasticizing agent; Solvent